Plus Therapeutics Competitors and Similar CompaniesClear all
Plus Therapeutics's competitors and similar companies include Praedicare Labs, Allogene Therapeutics, AVEO Pharmaceuticals, Cristal Therapeutics and Athenex.
 Plus Therapeutics Plus Therapeutics is a pharmaceutical company focused on the development of treatments for patients battling cancer and other life-threatening diseases. |  Praedicare Labs Praedicare Labs is a company providing drug development services for pre-clinical and early clinical phases. |  Allogene Therapeutics Allogene Therapeutics is a clinical-stage biotechnology company developing allogeneic chimeric antigen receptor T cell (AlloCAR T) products for cancer. |  AVEO Pharmaceuticals AVEO is a biopharmaceutical company focused on the discovery and development of targeted cancer therapeutics. |  Cristal Therapeutics Cristal Therapeutics is a clinical-stage pharmaceutical company developing targeted nanomedicines with therapeutic profiles for the treatment of cancer and other diseases. |  Athenex Athenex is a biopharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of cancer. | |
Founding Date | Founding Date 1996 | Founding Date 2018 | Founding Date 2018 | Founding Date 2001 | Founding Date 2011 | Founding Date 2003 |
Type | Type Public | Type Private | Type Public | Type Public | Type Private | Type Public |
Tags | ||||||
Locations | Locations Austin, US HQ San Antonio, US | Locations Farmers Branch, US HQ | Locations South San Francisco, US HQ | Locations Boston, US HQ | Locations Maastricht, NL HQ | |
Employees | Employees 1721% increase | Employees 814% increase | Employees 2263% decrease | Employees 1912% increase | Employees 4 | Employees 575 |
Valuation ($) | Valuation ($) 8 m | Valuation ($) N/A | Valuation ($) 585.5 m | Valuation ($) 515.6 m | Valuation ($) N/A | Valuation ($) 2.3 m |
Financial | ||||||
Revenue (est.) | Revenue (est.) $5.2m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $42.3m (FY, 2021) | Revenue (est.) N/A | Revenue (est.) $102.8m (FY, 2022) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods $4.7m (FY, 2021) | Cost of goods N/A | Cost of goods $76.1m (FY, 2022) |
Net income | Net income ($22.4m) (FY, 2025) | Net income N/A | Net income ($190.9m) (FY, 2025) | Net income ($53.3m) (FY, 2021) | Net income N/A | Net income ($104.4m) (FY, 2022) |
Funding | ||||||
Total funding raised | Total funding raised $ 71.9m | Total funding raised N/A | Total funding raised $ 532m | Total funding raised $ 224m | Total funding raised $ 26.8m | Total funding raised $ 252.1m |
For sources of this data, please see the company profile
View Company Profiles
Praedicare Labs
HQ
Farmers Branch, US
Employees
8↑ 14% increase
Praedicare Labs is a company providing drug development services for pre-clinical and early clinical phases.
View companyAllogene Therapeutics
HQ
South San Francisco, US
Employees
226↓ 3% decrease
Allogene Therapeutics is a clinical-stage biotechnology company developing allogeneic chimeric antigen receptor T cell (AlloCAR T) products for cancer.
View companyAVEO Pharmaceuticals
HQ
Boston, US
Employees
19↑ 12% increase
AVEO is a biopharmaceutical company focused on the discovery and development of targeted cancer therapeutics.
View companyCristal Therapeutics
HQ
Maastricht, NL
Employees
4
Cristal Therapeutics is a clinical-stage pharmaceutical company developing targeted nanomedicines with therapeutic profiles for the treatment of cancer and other diseases.
View company